New study confirms effectiveness of GC's EQUIA Forte

GC International

Tue. 3. October 2023

save

RHODES, Greece: Researchers have recently presented the results of a five-year multicentre clinical study involving the EQUIA Forte glass-hybrid restorative system from dental manufacturer GC. It found that the success and survival rates of EQUIA Forte are satisfactory and comparable to those of nano-hybrid resin composites for moderate to large two-surface restorations of molars.

An abstract of the study, titled “Five-year performance of glass-hybrid and nano-hybrid restoratives: Multi-centre clinical trial”, was presented at the 2023 Oral Health Research Congress in Rhodes, which was organised by the continental European division and the Scandinavian division of the International Association for Dental, Oral, and Craniofacial Research.

The long-term randomised split-mouth trial, which was conducted at dental schools in Croatia, Italy, Serbia and Turkey, compared the clinical performance of EQUIA Forte with that of the nano-hybrid composite Tetric EvoCeram (Ivoclar) in medium to large Class II restorations. In the trial, 180 patients underwent two-surface restorations of two molars in the same jaw using each of the restorative materials according to random allocation. After a period of five years, no statistically significant differences were observed in the overall success and survival rates of the two types of restorative material.

At the congress, Lead researcher Prof. Ivana Miletić from the University of Zagreb’s School of Dental Medicine said: “After five years of follow-up, our results demonstrate an excellent long-term success of glass-hybrid restorative materials. I am optimistic about these materials’ expanding the restorative options without compromising the treatment outcomes for our patients.”

The full report on the study will be published in a special issue of the Journal of Dental Research.

Tags:

To post a reply please login or register

Class II restoration with thermo-viscous composite

In an earlier article on this topic,1 I demonstrated the workability of thermo-viscous composites. After warming, the composite can be easily handled for ...

Large study ties poor childhood oral health to later heart risk

COPENHAGEN, Denmark: Poor oral health in childhood is known to have consequences far beyond the mouth, including effects on growth, and adult oral health ...

Empirical comparative study confirms thixotropic wound dressing for haemostasis

Haemostasis is fundamental to the prevention of excessive blood loss and for wound healing after injury, or wound setting. It is a basic prerequisite for ...

Combination of a distaliser and aligners for Class II correction

The distalisation of the maxillary posterior teeth is limited to approximately 2 mm when treated solely with aligners.1–3 This often results in dental ...

Study confirms dentists’ key role in oral cancer detection

TORONTO, Canada: A new study has shown that dentists are playing an important role in detecting oral cancer. After examining data gathered over an 11-year ...

Early diagnosis is key: GC Dental Campus webinar to discuss direct restorations for tooth wear

As pathological tooth wear becomes a more frequent concern in clinical practice, direct composite restorations are increasingly relevant as a minimally ...

Large study finds regional inequalities in accessing dental care in Japan

TSUKUBA, Japan: Healthcare can be considered a right or a luxury, depending on one’s location. Although essential for maintaining good health, healthcare ...

IDEX to provide world-class trade platform for dentistry in 2023

ISTANBUL, Turkey: The International Dental Equipment and Materials Exhibition (IDEX Istanbul) will be held from 25 to 28 May 2023 at the Istanbul Fair ...

Interceptive aligner treatment in a growing Class II, Division 1 patient

Early intervention in growing patients with skeletal Class II malocclusion aims to reduce sagittal discrepancies, guide dentofacial development and minimise...

Researchers conduct large study into oropharyngeal cancers

NEW YORK, U.S.: In the largest study of its kind, researchers from the Dana-Farber/Brigham and Women’s Cancer Center (DFBWCC) have sifted through the ...

Education

Live webinar
Thu. 25 June 2026
2:00 pm EST (New York)